Proper diagnosis effective for dry eye therapy

Article

A new golden age is here: the Golden Age of Dry Eye Management, according to one optometrist.

"We have large numbers of individuals from the baby boomer generation who are entering the dry eye time in their lives, and there's a greater awareness of dry eye in the first place, even with younger people," said Dr. Schachet, Eyecare Consultants-Vision Source, Englewood, CO. "We not only have the opportunity to dramatically help our patients, but also to own this segment of the marketplace."

Dr. Schachet said that with growing awareness of dry eye disease has come growing knowledge and changing paradigms, along with a new name: ocular surface disease.

The new paradigm begins with determining the etiology. The two major types of dry eye are aqueous deficient and evaporative. A correct diagnosis is essential to establish the proper therapy.

"If you don't have the proper diagnosis in the first place it doesn't matter what you do," Dr. Schachet said. "There's no way to 'shotgun' this and be effective."

Make the proper diagnosis

According to Dr. Schachet, history is the key to making the proper diagnosis. He recommended including these questions:

"Listen to the patient," Dr. Schachet said. "Covering key points in a thorough history will help you determine where to go with your testing."

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.